Cleton-Jansen AM - Search Results

1

Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type.

Vos CB, ter Haar NT, Rosenberg C, Peterse JL, Cleton-Jansen AM, Cornelisse CJ, van de Vijver MJ. Vos CB, et al. Br J Cancer. 1999 Dec;81(8):1410-8. doi: 10.1038/sj.bjc.6693372. Br J Cancer. 1999. PMID: 10604741 Free PMC article.

2

At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer.

Cleton-Jansen AM, Moerland EW, Kuipers-Dijkshoorn NJ, Callen DF, Sutherland GR, Hansen B, Devilee P, Cornelisse CJ. Cleton-Jansen AM, et al. Genes Chromosomes Cancer. 1994 Feb;9(2):101-7. doi: 10.1002/gcc.2870090205. Genes Chromosomes Cancer. 1994. PMID: 7513539

3

Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13.

Cleton-Jansen AM, Collins N, Lakhani SR, Weissenbach J, Devilee P, Cornelisse CJ, Stratton MR. Cleton-Jansen AM, et al. Br J Cancer. 1995 Nov;72(5):1241-4. doi: 10.1038/bjc.1995.493. Br J Cancer. 1995. PMID: 7577475 Free PMC article.

4

Mapping of the breast basic conserved gene (D16S444E) to human chromosome band 16q24.3.

Cleton-Jansen AM, Moerland HW, Callen DF, Doggett NA, Devilee P, Cornelisse CJ. Cleton-Jansen AM, et al. Cytogenet Cell Genet. 1995;68(1-2):49-51. doi: 10.1159/000133886. Cytogenet Cell Genet. 1995. PMID: 7956357

5

Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.

Cornelis RS, van Vliet M, Vos CB, Cleton-Jansen AM, van de Vijver MJ, Peterse JL, Khan PM, Børresen AL, Cornelisse CJ, Devilee P. Cornelis RS, et al. Cancer Res. 1994 Aug 1;54(15):4200-6. Cancer Res. 1994. PMID: 8033152

6

Evidence for limited molecular genetic heterogeneity as defined by allelotyping and clonal analysis in nine metastatic breast carcinomas.

Bonsing BA, Devilee P, Cleton-Jansen AM, Kuipers-Dijkshoorn N, Fleuren GJ, Cornelisse CJ. Bonsing BA, et al. Cancer Res. 1993 Aug 15;53(16):3804-11. Cancer Res. 1993. PMID: 8101767

7

E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.

Berx G, Cleton-Jansen AM, Nollet F, de Leeuw WJ, van de Vijver M, Cornelisse C, van Roy F. Berx G, et al. EMBO J. 1995 Dec 15;14(24):6107-15. doi: 10.1002/j.1460-2075.1995.tb00301.x. EMBO J. 1995. PMID: 8557030 Free PMC article.

8

The majority of 22 Dutch high-risk breast cancer families are due to either BRCA1 or BRCA2.

Peelen T, Cornelis RS, van Vliet M, Petrij-Bosch A, Cleton-Jansen AM, Meijers-Heijboer H, Klijn JG, Vasen HF, Cornelisse CJ, Devilee P. Peelen T, et al. Eur J Hum Genet. 1996;4(4):225-30. doi: 10.1159/000472203. Eur J Hum Genet. 1996. PMID: 8875189

9

E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain.

Berx G, Cleton-Jansen AM, Strumane K, de Leeuw WJ, Nollet F, van Roy F, Cornelisse C. Berx G, et al. Oncogene. 1996 Nov 7;13(9):1919-25. Oncogene. 1996. PMID: 8934538

10

Loss of heterozygosity at 7q31 in breast cancer: results from an International Collaborative Study Group. The Breast Cancer Somatic Genetics Consortium.

Devilee P, Hermans J, Eyfjörd J, Bøorresen AL, Lidereau R, Sobol H, Borg A, Cleton-Jansen AM, Oláh E, Cohen BB, Scherneck S, Hamann U, Peterlin B, Caligo M, Bignon YJ, Maugard C. Devilee P, et al. Genes Chromosomes Cancer. 1997 Mar;18(3):193-9. Genes Chromosomes Cancer. 1997. PMID: 9071572

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

189 results

Search Page

Filters